Lupin

Lupin receives tentative approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride tablets

Read more

Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules

Read more

Lupin receives EIR from U.S. FDA for its Dabhasa facility

Read more

Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER tablets

Read more

Lupin receives tentative approval for Olopatadine Hydrochloride Ophthalmic Solution

Read more

Lupin gains EIR from US FDA for its Somerset manufacturing facility

Read more

Lupin appoints Abdelaziz Toumi as CEO of its API CDMO subsidiary

Read more

Lupin announces closure of US FDA inspection

Read more

Lupin, Fuji sign agreement to commercialise Nextstellis in Vietnam, Philippines

Read more

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

Read more